Similarities in the pattern of regional brain dysfunction in negative schizophrenia and unipolar depression: A single photon emission-computed tomography and auditory evoked potentials study

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 25, Issue 5, 2001, Pages 993-1009

  Medved, Vesna ^a   Petrović, Ratko ^b   Išgum, Velimir ^c   Szirovicza, Lajos ^d   Hotujac, Ljubomir ^a  

^a KBC Rebro   (Croatia)

^b Diabetes and Metabolic Diseases   (Croatia)

^c KBC Zagreb   (Croatia)

^d INSTITUTE FOR ANTHROPOLOGICAL RESEARCH   (Croatia)

Author keywords

Auditory evoked potentials (AEPs); Biological psychiatry; Depression; Frontal brain regions; Schizophrenia; Single photon emission computed tomography (SPECT)

Indexed keywords

ADULT; ARTICLE; BASAL GANGLION; BLOOD FLOWMETRY; BRAIN PERFUSION; BRAIN REGION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; DIFFERENTIAL DIAGNOSIS; EVOKED AUDITORY RESPONSE; FEMALE; HAMILTON SCALE; HIPPOCAMPUS; HUMAN; LATENT PERIOD; NEGATIVE SYNDROME; RATING SCALE; SIGNAL PROCESSING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; BRAIN; DEPRESSIVE DISORDER; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; MALE; MIDDLE AGED; REACTION TIME; SCHIZOPHRENIA; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0034892211     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(01)00172-5     Document Type: Article

References (53)

1. Hypofrontahty in schizophrenia: Distributed dysfunctional circuits in neuroleptic-naïve patients
2. Cerebral metabolic rates for glucose in mood disorders studied with positron emission tomography (PET) and (F-18)-fluoro-2-deoxyglucose (FDG)
3. Frontal and parietal metabolic disturbances in unipolar depression
4. Reliability and validity of emotional blunting as a criterion for diagnosis of schizophrenia
5. Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders
6. Glucose metabolic rate in normals and schizophrenics during the continuous performance test assessed by positron emission tomography
7. P300 delay and attenuation in schizophrenia: Reversal by neuroleptic medication
8. Quantitative iodine-123 IMP imaging of brain perfusion in schizophrenia
9. Schizophrenia - A brain disease?
10. Increased temporal lobe glucose use in chronic schizophrenic patients
11. P300 in major depressive disorder
12. Functional neuroimaging studies of depression: The anatomy of melancholia
13. 99mTc-exametazine in unmedicated schizophrenic patients
14. Active and remitted schizophrenia: Psychopathological and regional cerebral blood flow findings
15. Hypofrontality and negative symptoms in major depressive disorder
16. Negative symptoms in schizophrenia: Neurobiological models and treatment response
17. Imaging strategies in depression
18. Laterality in functional brain imaging studies of schizophrenia
19. A rating scale for depression
20. Single photon emission computerised tomography (SPECT) in schizophrenia
21. Diagnostic issues in chronic schizophrenia: Kraepelinian schizophrenia, undifferentiated schizophrenia, and state-independent negative symptoms
22. Brain imaging of affective disorders and schizophrenia
23. Depressive and negative symptoms in major psychiatric disorders
24. Temporal lobe dysfunction and correlation of regional cerebral blood flow abnormalities with psychopathology in schizophrenia and major depression - A study with single photon emission computed tomography
25. Auditory event-related potentials and clinical scores in unmedicated schizophrenic patients
26. Brain metabolism quantification in psychiatric research
27. Frontal cortex and behavior
28. Positive and negative symptoms and regional cerebral perfusion in antipsychotic-naïve schizophrenic patients: A high-resolution SPECT study
29. Cerebral perfusion correlates of negative symptomatology and parkinsonism in a sample of treatment-refractory schizophrenics: An exploratory 99mTc-HMPAO SPECT study
30. Increased rate of P300 latency prolongation with age in schizophrenia
31. Changes in regional brain activity in major depression after successful treatment with antidepressant drugs
32. Temporal lobe perfusion asymmetries in schizophrenia
33. U. Regional cerebral blood flow and negative/positive symptoms in 24 drug-naive schizophrenics
34. First-episode schizophrenic psychosis differs from first-episode affective psychosis and controls in P300 amplitude over left temporal lobe
35. Regional cerebral bloof flow in endogenous psychoses: A Tc 99m HMPAO-SPECT pilot study
36. Regional cerebral blood flow in first-episode schizophrenia patients before and after antipsychotic drug treatment
37. Brain activation during an auditory 'oddball task' in schizophrenia measured by single photon emission tomography
38. Positron emission tomographic scanning in predominantly never-treated acute schizophrenioc patients
39. Prefrontal cortex activity in people with schizophrenia and control subjects
40. Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia
41. Auditory event related potentials in major depression: Prolonged P300 latency and increased P200 amplitude
42. 99mTc-hexamethylpropyleneamine oxime SPECT in elderly depressed patients
43. Differential pathophysiological mechanisms of reduced P300 amplitude in schizophrenia and depression
44. Focal changes in cerebral blood flow produced by monetary incentive during a mental mathematics task in normal and depressed subjects
45. The distribution and latency of the auditory P300 in schizophrenia and depression
46. PET studies of glucose metabolism in patients with schizophrenia
47. Regional brain glucose metabolism in drug free schizophrenic patients and clinical correlates
48. Distinguishing depressive and negative symptoms in chronic schizophrenia
49. Schizophrenia and the frontal brain: A quantitative review